Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Maravai LifeSciences Q2 Sales $73.400M Beat $71.634M Estimate

Author: Benzinga Newsdesk | August 07, 2024 05:20pm
Maravai LifeSciences (NASDAQ:MRVI) reported quarterly sales of $73.400 million which beat the analyst consensus estimate of $71.634 million by 2.46 percent. This is a 6.51 percent increase over sales of $68.914 million the same period last year.

Posted In: MRVI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist